{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Familial cerebral small vessel disease",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_aspirin",
          "name": "Aspirin"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_cilostazol",
          "name": "Cilostazol"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_clopidogrel",
          "name": "Clopidogrel"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_warfarin",
          "name": "Warfarin"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_rivaroxaban",
          "name": "Rivaroxaban"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_dabigatran",
          "name": "Dabigatran"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_edoxaban",
          "name": "Edoxaban"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_prasugrel",
          "name": "Prasugrel"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_heparin",
          "name": "Heparin"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_ticlopidine",
          "name": "Ticlopidine"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_fondaparinux",
          "name": "Fondaparinux"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_enoxaparin",
          "name": "Enoxaparin"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_aspirin",
          "type": "Drug",
          "label": "Aspirin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_cilostazol",
          "type": "Drug",
          "label": "Cilostazol",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_clopidogrel",
          "type": "Drug",
          "label": "Clopidogrel",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_warfarin",
          "type": "Drug",
          "label": "Warfarin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_rivaroxaban",
          "type": "Drug",
          "label": "Rivaroxaban",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_dabigatran",
          "type": "Drug",
          "label": "Dabigatran",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_edoxaban",
          "type": "Drug",
          "label": "Edoxaban",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_prasugrel",
          "type": "Drug",
          "label": "Prasugrel",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_heparin",
          "type": "Drug",
          "label": "Heparin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ticlopidine",
          "type": "Drug",
          "label": "Ticlopidine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_fondaparinux",
          "type": "Drug",
          "label": "Fondaparinux",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_enoxaparin",
          "type": "Drug",
          "label": "Enoxaparin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_familial_cerebral_small_vessel_disease",
          "type": "Disease",
          "label": "Familial Cerebral Small Vessel Disease",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "n_aspirin",
          "target": "n_familial_cerebral_small_vessel_disease",
          "relation": "contraindication",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "常识性认知，阿司匹林可能加重出血风险"
        },
        {
          "source": "n_cilostazol",
          "target": "n_familial_cerebral_small_vessel_disease",
          "relation": "contraindication",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "同类药物特性，可能影响血管反应"
        },
        {
          "source": "n_clopidogrel",
          "target": "n_familial_cerebral_small_vessel_disease",
          "relation": "contraindication",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "常见对抗血小板药的潜在出血风险"
        },
        {
          "source": "n_warfarin",
          "target": "n_familial_cerebral_small_vessel_disease",
          "relation": "contraindication",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "战争林与小血管病交互影响预估"
        },
        {
          "source": "n_rivaroxaban",
          "target": "n_familial_cerebral_small_vessel_disease",
          "relation": "contraindication",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "估计的出血风险增加"
        },
        {
          "source": "n_dabigatran",
          "target": "n_familial_cerebral_small_vessel_disease",
          "relation": "contraindication",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "血液稀释与出血风险相关"
        },
        {
          "source": "n_edoxaban",
          "target": "n_familial_cerebral_small_vessel_disease",
          "relation": "contraindication",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "潜在的出血风险"
        },
        {
          "source": "n_prasugrel",
          "target": "n_familial_cerebral_small_vessel_disease",
          "relation": "contraindication",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "抗血小板效应可能加剧"
        },
        {
          "source": "n_heparin",
          "target": "n_familial_cerebral_small_vessel_disease",
          "relation": "contraindication",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "快速反馈的出血风险"
        },
        {
          "source": "n_ticlopidine",
          "target": "n_familial_cerebral_small_vessel_disease",
          "relation": "contraindication",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "影响血小板功能"
        },
        {
          "source": "n_fondaparinux",
          "target": "n_familial_cerebral_small_vessel_disease",
          "relation": "contraindication",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "类似药物的潜在风险"
        },
        {
          "source": "n_enoxaparin",
          "target": "n_familial_cerebral_small_vessel_disease",
          "relation": "contraindication",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "抗凝治疗的出血风险估计"
        }
      ]
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "上述药物在处理家族性脑小血管病时可能存在禁忌",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "所有药物的安全性和适应症分析基于目前的临床常识"
    ],
    "uncertainties": [
      "实际临床上的适应性还需进一步研究验证"
    ],
    "next_focus_for_pi": [
      "是否需要进一步验证不同药物与家族性脑小血管病的具体相互作用"
    ]
  }
}